Advent Technologies (ADN) Q4 2025 earnings summary

Executive summary

• Revenue increased 113% year-over-year to $3.3 million, driven by more Joint Development Agreements.

• Net loss narrowed to $41.0 million from $71.4 million in 2023, reflecting cost reductions and lower R&D and admin expenses.

• Company faces substantial doubt about its ability to continue as a going concern due to negative cash flow and liquidity constraints.

• Significant cost-cutting, staff reductions, and asset sales were implemented to conserve cash.

• Ongoing strategic partnerships with Airbus, Hyundai, and the US DoD, and major EU grant awards support future growth.

Financial highlights

• Revenue rose to $3.3 million from $1.5 million year-over-year, mainly from JDAs.

• Cost of revenues dropped to $1.5 million from $7.0 million, reflecting a shift from product sales to JDAs.

• Net loss from continuing operations improved to $30.0 million from $51.0 million.

• Cash and cash equivalents at year-end were $0.4 million, with a working capital deficit of $26.1 million.

• Adjusted EBITDA improved by $31.1 million year-over-year, but remains negative.

Outlook and guidance

• Management expects increased demand for MEAs and fuel cell systems as production scales.

• Ongoing cost control and capital raising are critical for near-term survival.

• Substantial doubt remains about the ability to continue as a going concern without new funding.

• Focus remains on strategic partnerships, licensing, and grant-funded R&D.